background image

Paid Clinical Trials Minnesota

Discover 1,875 paid clinical trials in Minnesota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves

Recruiting

Sponsor:

Edwards Lifesciences

Location:

Rochester, Lisle, Evanston, Wichitashow 25 more

Code:

NCT05172973

Conditions

Aortic Valve Insufficiency

Aortic Valve Stenosis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

SAPIEN X4 THV

A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

Recruiting
PHASE1
PHASE2

Sponsor:

Takeda

Location:

Minneapolis, Sioux Falls, Indianapolis, Aurorashow 7 more

Code:

NCT04844073

Conditions

Squamous Cell Cancer of Head and Neck (SCCHN)

Non-small Cell Lung Cancer (NSCLC)

Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAK-186

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Recruiting

Sponsor:

American Thrombosis and Hemostasis Network

Location:

Minneapolis, Rochester, Kansas City, Lansingshow 19 more

Code:

NCT04647227

Conditions

Hemophilia A With Inhibitor

Hemophilia B With Inhibitor

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

coagulation factor VIIa [recombinant]-jncw

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Recruiting
PHASE3

Sponsor:

Melt Pharmaceuticals

Location:

Alexandria, Fargo, W. Fargo, Sioux Fallsshow 8 more

Code:

NCT06383273

Conditions

Cataract

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

MELT-300 sublingual tablet

Midalozam sublingual tablet

Placebo sublingual tablet

KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

Recruiting

Sponsor:

Known Medicine, Inc.

Location:

Rochester, Durham, Houston

Code:

NCT05338073

Conditions

Cancer

Predictive Cancer Model

Effects of Chemotherapy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Known 3Dx Test

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Recruiting
PHASE3

Sponsor:

Priovant Therapeutics, Inc.

Location:

Minneapolis, Rochester, Madison, Omahashow 33 more

Code:

NCT06431373

Conditions

Uveitis, Posterior

Uveitis, Intermediate

Uveitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Brepocitinib PO QD

Placebo PO QD

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

Recruiting

Sponsor:

Dennis M. McNamara, MD, MS

Location:

Minneapolis, Rochester, Iowa City, Milwaukeeshow 43 more

Code:

NCT05180773

Conditions

Peripartum Cardiomyopathy, Postpartum

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bromocriptine

Placebo

Guideline Directed Medical Therapy for Heart Failure (GDMT)

Rivaroxaban

Second Placebo

A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

Recruiting
PHASE1
PHASE2

Sponsor:

Amgen

Location:

Saint Paul, Ann Arbor, Indianapolis, Denvershow 10 more

Code:

NCT05975073

Conditions

MTAP-null Non-Small-Cell Lung Cancer

MTAP-null Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AMG 193

IDE397

Corticosteroid Injection Versus Nerve Block

Recruiting

Sponsor:

University of Minnesota

Location:

Minneapolis

Code:

NCT06735027

Conditions

Glenohumeral Arthritis

Rotator Cuff Arthropathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

intraarticular corticosteroid injection (IACI)

suprascapular nerve block (SSNB)

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting
PHASE3

Sponsor:

Sanofi

Location:

Plymouth, Minneapolis, Fargo, Iowa Cityshow 78 more

Code:

NCT06141473

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Frexalimab

Teriflunomide

Placebo infusion

Placebo tablet

MRI contrast-enhancing agents

Popular cities in Minnesota

Minnesota offers a strong healthcare network and renowned medical research institutions, making it a prominent hub for a wide range of clinical trials. Leading organizations such as the Mayo Clinic, University of Minnesota Medical School, and Hennepin Healthcare are at the forefront of cutting-edge research.

These institutions are recognized globally for their contributions to medical advancements, placing Minnesota as a key player in clinical trials across various medical fields, from cancer and cardiovascular research to neurological and rare diseases.

Why choose Minnesota for clinical trials?

Common conditions studied in Minnesota

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Minnesota